Next Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
AAM
FHA
AUB
Next Financial Group's HQL Position: Q4 2021 in Review
Next Financial Group increased its abrdn Life Sciences Investors (HQL) stake by 18% in Q4 2021, buying an estimated $117K and bringing the position to 38,560 shares worth $742K. The position accounts for 0.05% of the portfolio, ranked #397.
Next Financial Group first reported a position in HQL in Q2 2014 and has held it in 24 quarters since. 67 funds tracked by Wall St. Rank hold HQL as of Q4 2021.
- Next Financial Group held 38,560 shares of abrdn Life Sciences Investors worth $742K as of Q4 2021.
- Next Financial Group bought 5,793 abrdn Life Sciences Investors shares in Q4 2021, an estimated $117K.
- abrdn Life Sciences Investors made up 0.05% of Next Financial Group's portfolio in Q4 2021, its #397 holding.
- Next Financial Group first reported a position in abrdn Life Sciences Investors in Q2 2014 and has held it in 24 quarters since.
- 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.